RhumbLine Advisers’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $175K | Buy |
155,858
+5,610
| +4% | +$6.28K | ﹤0.01% | 3304 |
|
|
2025
Q1 | $119K | Sell |
150,248
-8,924
| -6% | -$7.05K | ﹤0.01% | 3330 |
|
|
2024
Q4 | $263K | Buy |
159,172
+2,174
| +1% | +$3.59K | ﹤0.01% | 3067 |
|
|
2024
Q3 | $549K | Sell |
156,998
-3,003
| -2% | -$10.5K | ﹤0.01% | 2640 |
|
|
2024
Q2 | $525K | Buy |
160,001
+15,825
| +11% | +$51.9K | ﹤0.01% | 2649 |
|
|
2024
Q1 | $1.06M | Buy |
144,176
+3,841
| +3% | +$28.2K | ﹤0.01% | 2222 |
|
|
2023
Q4 | $525K | Sell |
140,335
-7
| -0% | -$26 | ﹤0.01% | 2628 |
|
|
2023
Q3 | $298K | Buy |
140,342
+1,634
| +1% | +$3.46K | ﹤0.01% | 2940 |
|
|
2023
Q2 | $660K | Buy |
138,708
+22,159
| +19% | +$105K | ﹤0.01% | 2515 |
|
|
2023
Q1 | $664K | Buy |
116,549
+2,608
| +2% | +$14.9K | ﹤0.01% | 2306 |
|
|
2022
Q4 | $1.15M | Buy |
113,941
+3,588
| +3% | +$36.2K | ﹤0.01% | 2054 |
|
|
2022
Q3 | $2.47M | Buy |
110,353
+8,975
| +9% | +$201K | ﹤0.01% | 1641 |
|
|
2022
Q2 | $2.51M | Buy |
101,378
+11,996
| +13% | +$297K | ﹤0.01% | 1648 |
|
|
2022
Q1 | $3.47M | Buy |
89,382
+758
| +0.9% | +$29.4K | ﹤0.01% | 1541 |
|
|
2021
Q4 | $5.19M | Sell |
88,624
-3,049
| -3% | -$178K | 0.01% | 1334 |
|
|
2021
Q3 | $5.43M | Buy |
91,673
+2,109
| +2% | +$125K | 0.01% | 1315 |
|
|
2021
Q2 | $7.77M | Buy |
89,564
+37
| +0% | +$3.21K | 0.01% | 1159 |
|
|
2021
Q1 | $7.38M | Sell |
89,527
-5,738
| -6% | -$473K | 0.01% | 1182 |
|
|
2020
Q4 | $8.66M | Buy |
95,265
+5,871
| +7% | +$534K | 0.01% | 1019 |
|
|
2020
Q3 | $3.57M | Sell |
89,394
-13,494
| -13% | -$539K | 0.01% | 1360 |
|
|
2020
Q2 | $3.53M | Buy |
102,888
+14,908
| +17% | +$511K | 0.01% | 1403 |
|
|
2020
Q1 | $1.95M | Buy |
87,980
+3,290
| +4% | +$73.1K | ﹤0.01% | 1559 |
|
|
2019
Q4 | $1.66M | Buy |
84,690
+6,875
| +9% | +$135K | ﹤0.01% | 1868 |
|
|
2019
Q3 | $1.21M | Buy |
77,815
+721
| +0.9% | +$11.2K | ﹤0.01% | 1949 |
|
|
2019
Q2 | $1.57M | Sell |
77,094
-3,126
| -4% | -$63.5K | ﹤0.01% | 1871 |
|
|
2019
Q1 | $1.41M | Buy |
80,220
+841
| +1% | +$14.8K | ﹤0.01% | 1885 |
|
|
2018
Q4 | $1.02M | Buy |
79,379
+35,315
| +80% | +$453K | ﹤0.01% | 2001 |
|
|
2018
Q3 | $718K | Sell |
44,064
-3,050
| -6% | -$49.7K | ﹤0.01% | 2138 |
|
|
2018
Q2 | $534K | Buy |
47,114
+2,728
| +6% | +$30.9K | ﹤0.01% | 2278 |
|
|
2018
Q1 | $433K | Buy |
44,386
+10,946
| +33% | +$107K | ﹤0.01% | 2270 |
|
|
2017
Q4 | $204K | Sell |
33,440
-8,087
| -19% | -$49.3K | ﹤0.01% | 2622 |
|
|
2017
Q3 | $164K | Buy |
41,527
+560
| +1% | +$2.21K | ﹤0.01% | 2801 |
|
|
2017
Q2 | $133K | Buy |
+40,967
| New | +$133K | ﹤0.01% | 2860 |
|